PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications...

[引用][C] EXABS-137-LYM Circulating Tumor DNA In Lymphoma: When Will It Be Ready for Prime Time?

M Roschewski - Clinical Lymphoma Myeloma and Leukemia, 2023 - Elsevier
相关文章